Current Management of Primary Immune Thrombocytopenia
dc.contributor.author | Provan, D | en_US |
dc.contributor.author | Newland, AC | en_US |
dc.date.accessioned | 2016-01-06T15:57:24Z | |
dc.date.issued | 2015-10 | en_US |
dc.date.submitted | 2015-11-04T15:40:47.723Z | |
dc.identifier.issn | 0741-238X | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/10350 | |
dc.description | This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License | en_US |
dc.format.extent | 875 - 887 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | ADVANCES IN THERAPY | en_US |
dc.subject | Eltrombopag | en_US |
dc.subject | Immune thrombocytopenia | en_US |
dc.subject | ITP | en_US |
dc.subject | Management | en_US |
dc.subject | Romiplostim | en_US |
dc.subject | Second-line therapy | en_US |
dc.subject | Sustained responses | en_US |
dc.subject | TPO receptor agonists | en_US |
dc.title | Current Management of Primary Immune Thrombocytopenia | en_US |
dc.type | Article | |
dc.rights.holder | 2015. The authors | |
dc.rights.holder | 2015. The authors | |
dc.identifier.doi | 10.1007/s12325-015-0251-z | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365796200001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 10 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 32 | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Centre for Immunobiology [1152]